4//SEC Filing
Banks Jerel A. 4
Accession 0001062993-24-020464
CIK 0001808898other
Filed
Dec 10, 7:00 PM ET
Accepted
Dec 11, 5:19 PM ET
Size
5.1 KB
Accession
0001062993-24-020464
Insider Transaction Report
Form 4
Banks Jerel A.
DirectorChief Executive Officer
Transactions
- Award
Options (right to buy)
2024-12-09+2,310,000→ 2,310,000 totalExercise: $12.18Exp: 2034-12-09→ Common Stock (2,310,000 underlying)
Footnotes (1)
- [F1]The stock options will vest in 16 substantially equal quarterly installments commencing on March 31, 2025.
Issuer
Benitec Biopharma Inc.
CIK 0001808898
Entity typeother
Related Parties
1- filerCIK 0001808930
Filing Metadata
- Form type
- 4
- Filed
- Dec 10, 7:00 PM ET
- Accepted
- Dec 11, 5:19 PM ET
- Size
- 5.1 KB